Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-12-04T20:20:46.815Z Has data issue: false hasContentIssue false

Deep Brain Stimulation: Current State of the Art

Published online by Cambridge University Press:  15 April 2020

D. Ferreira
Affiliation:
Psychiatry and Mental Health, Hospital de Santa Maria, LISBOA, Portugal
A. Guerra
Affiliation:
Psychiatry and Mental Health, Hospital de Santa Maria, LISBOA, Portugal
A. Gonçalves-Ferreira
Affiliation:
Neurosurgery, Hospital de Santa Maria, LISBOA, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The limitations of the available treatment options for psychiatric disorders have spurred interest in different therapeutic methods. Deep Brain Stimulation (DBS) has been researched as a surgical therapeutic approach for treatment resistant patients with psychiatric disorders such as Depression and Obsessive-Compulsive Disorder (OCD), Gilles la Tourette syndrome, Addiction and Anorexia Nervosa.

Objective

To review the current existing evidence base for DBS in the different psychiatric and neuropsychiatric disorders.

Method

A literature review was performed through MEDLINE/PsycINFO, using the following keywords: ”DBS”, ‘Deep-brain Stimulation”, ‘Psychiatry”, ‘Disorder”, ‘Depression”, ‘Obsessive Compulsive Disorder”, ‘Addiction”, ‘Anorexia”, ‘Alcohol”, ‘Heroin”, ‘Gilles la Tourette”, “PTSD". All relevant papers published until the 30<sup>th</sup> of September 2014, were selected.

Results

A growing body of evidence seems to demonstrate that DBS is effective as a therapeutic approach for treatment-resistant Depression and OCD. Newer fields of research in DBS include Addiction (Alcohol, Heroin, Cocaine), Gilles la Tourette syndrome and, more recently even, Anorexia Nervosa. Regarding Addiction, there are few studies, with small patient samples, and with mixed results regarding clinical improvement. Existing evidence for Anorexia Nervosa is also scarce, but seems to demonstrate positives results in terms of effectiveness. Concerning Gilles la Tourette syndrome, there is a somewhat larger evidence base pointing to clinical improvement following DBS. Research in Post-Traumatic Stress Disorder is currently under way.

Conclusion

DBS is developing to become a valid therapeutic option for the treatment of some refractory psychiatric disorders. More clinical experience and scientific evidence is necessary to improve its effectiveness.

Type
Article: 0838
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.